Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol 200 µg vs 400 µg for cervical dilatation in miscarriage
NCT02957305Phase 4Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Dec 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of misoprostol in spontaneous abortion, sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Number of Participants Who Required Cervix Dilation at Initiation of the Manual Vacuum Aspiration at 6 hours. Started Dec 2016; status: completed.
02
Drugs
misoprostol
03
Conditions
spontaneous abortion
Beyond the preview
Go deeper on NCT02957305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957305.